Stock DNA
Healthcare Services
INR 32 Cr (Micro Cap)
132.00
99
0.00%
1.02
0.93%
1.21
Total Returns (Price + Dividend) 
Latest dividend: 0.1 per share ex-dividend date: Sep-22-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Bandaram Pharma Packtech Ltd Reports Mixed Quarterly Results Amid Financial Trend Shift
Bandaram Pharma Packtech Ltd has posted a mixed set of results for the quarter ended September 2026, with robust revenue growth contrasting against continued earnings pressure. While net sales surged by over 56%, the company’s earnings per share remained in negative territory, reflecting ongoing margin challenges in the healthcare services sector.
Read More
Bandaram Pharma Packtech Ltd is Rated Sell
Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 October 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read More
Bandaram Pharma Packtech Ltd is Rated Sell
Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 02 October 2026, providing investors with an up-to-date analysis of the company’s standing.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-Oct-2026 | Source : BSENewspaper Publication of financial results for quater and half-year ended 30.09.2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 29.10.2026
29-Oct-2026 | Source : BSEOutcome of Board Meeting held on 29.10.2026
Results For Quater And Half-Year Ended 30.09.2026
29-Oct-2026 | Source : BSEResults for Quater and half- year ended 30.09.2026
Corporate Actions 
No Upcoming Board Meetings
Bandaram Pharma Packtech Ltd has declared 1% dividend, ex-date: 22 Sep 25
No Splits history available
No Bonus history available
Bandaram Pharma Packtech Ltd has announced 3:1 rights issue, ex-date: 30 Jun 23
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Deepak Reddy B (35.28%)
Sanivarapu Jhansi (4.37%)
36.17%
Quarterly Results Snapshot (Consolidated) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 56.34% vs 92.97% in Sep 2025
YoY Growth in quarter ended Sep 2026 is -833.33% vs -95.52% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 18.19% vs 8.84% in Sep 2024
Growth in half year ended Sep 2025 is -87.06% vs 347.37% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 28.80% vs 17.02% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -64.29% vs 170.97% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 70.24% vs 8.45% in Mar 2025
YoY Growth in year ended Mar 2026 is -180.00% vs -42.11% in Mar 2025